Published in Curr Treat Options Gastroenterol on December 01, 2002
Bacteriologic study of cirrhotic patients with non-neutrocytic ascites. Gastroenterol Hepatol Bed Bench (2014) 0.75
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology (2000) 9.74
Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med (1999) 5.89
Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol (2000) 3.43
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology (2002) 2.93
Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91
Treatment of hepatic encephalopathy. N Engl J Med (1997) 2.60
A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med (2000) 2.20
Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology (1999) 2.18
Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology (1996) 2.00
Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology (2001) 1.91
Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis. Am J Gastroenterol (1999) 1.82
Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology (1999) 1.74
Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology (1988) 1.73
Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology (1998) 1.60
Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels. Gastroenterology (1999) 1.59
Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial. Ann Intern Med (1995) 1.59
Long-term prognosis of cirrhosis after spontaneous bacterial peritonitis treated with ceftriaxone. J Clin Gastroenterol (2001) 1.56
Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis. Am J Gastroenterol (2001) 1.56
Prognosis assessment of cirrhotic patients with refractory ascites treated with a peritoneovenous shunt. Am J Gastroenterol (1995) 1.46
A cost analysis of long term antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhosis. Am J Gastroenterol (1998) 1.42
Spontaneous bacterial peritonitis--in-hospital mortality, predictors of survival, and health care costs from 1988 to 1998. Am J Gastroenterol (2001) 1.37
Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Am J Gastroenterol (2001) 1.32
Effects of oral ciprofloxacin on aerobic gram-negative fecal flora in patients with cirrhosis: results of short- and long-term administration, with daily and weekly dosages. J Hepatol (1998) 1.32
Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial. J Hepatol (1998) 1.20
Translocated intestinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: molecular epidemiologic evidence. J Hepatol (1998) 1.19
Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study. J Hepatol (2000) 1.17
Dietary management of hepatic encephalopathy in cirrhotic patients: survey of current practice in United Kingdom. BMJ (1999) 1.07
Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients. J Hepatol (2000) 1.07
Impact of shunt surgery for variceal bleeding in the natural history of ascites in cirrhosis: a retrospective study. Hepatology (1994) 0.98
Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients. Hepatology (1999) 0.96
Long-lasting NO overproduction in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology (1997) 0.95
Expression of proinflammatory cytokines and their inhibitors during the course of spontaneous bacterial peritonitis. Dig Dis Sci (2001) 0.93
Prevalence and prognostic significance of bacterascites in cirrhosis with ascites. Dig Dis Sci (1995) 0.88
Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. A retrospective study of 229 spontaneous bacterial peritonitis episodes. J Hepatol (1997) 0.88
Bacterial peritonitis after elective endoscopic variceal ligation: a prospective study. Am J Gastroenterol (2000) 0.86
Cost-analysis of prophylactic antibiotics in spontaneous bacterial peritonitis. Gastroenterology (1997) 0.80
Antibiotic prophylaxis for spontaneous bacterial peritonitis: how and whom? J Hepatol (1998) 0.75
Liver transplantation after an acute episode of spontaneous bacterial peritonitis. Hepatogastroenterology (1997) 0.75
Spontaneous bacterial peritonitis: keys to management. Hosp Pract (1995) (2000) 0.75
Hyponatremia: pathophysiology, differential diagnosis and new aspects of treatment. Clin Nephrol (1996) 0.75